Definitive Contract 75A50323C00027
Award Date
9/22/23
Potential Completion Date
9/21/24
Potential Value
$9.9M
Ultimate Awardee
Pfizer Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order contract awarded by the U.S. Secret Service to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., for the purchase of DuoDote auto-injector packs. The contract has a ceiling value of $70,111.80 and a completion date of May 5, 2018. Meridian Medical Technologies has a history of providing medical training devices, auto-injector kits, and nerve agent antidote treatments to various federal agencies, including the Department of...
This federal contract award from the Office of Land and Emergency Management, a civilian agency, is for the procurement of AUTO-INJECTORS FOR NERVE AGENT EXPOSURE. The prime contractor is Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. and a manufacturer of medical countermeasures, particularly autoinjector devices and nerve agent antidote treatments. The contract is a firm-fixed-price purchase order with a ceiling value of $27,529.20 and a completion date of May...
This is a firm-fixed-price purchase order awarded by the U.S. Marshals Service Tactical Operations Division to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The $15,514.80 contract is for the delivery of auto-injectors containing the nerve agent antidotes atropine and pralidoxime. The contract does not utilize any set-aside designations. Meridian Medical Technologies is a key provider of auto-injector devices and nerve agent antidote treatments across the federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The contract is for $3,262,840.74 to provide 4522513207 ANTIDOTE TREATMENT products. Meridian Medical Technologies is a manufacturer of pharmaceutical products and medical devices, including nerve agent antidote treatments and autoinjector kits. This contract does not have a set-aside designation. Meridian has a...
This is a $660,839.00 firm fixed price definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Meridian Medical Technologies, LLC, a for-profit limited liability company that manufactures medical devices and provides medical training services. The contract has a completion date of February 15, 2019 and was awarded on August 1, 2018 without any set-aside designation. The contract was awarded under a Special...
This is a $41,936,532.62 cost-plus-incentive contract awarded by the Joint PEO Chemical and Biological Defense, a suborganization of the U.S. Department of Defense, to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The contract is for the development and delivery of Food and Drug Administration (FDA) approved products, with a completion date of December 16, 2024. Meridian is a manufacturer of medical countermeasures, specializing in autoinjector devices and nerve...
Meridian Medical Technologies, LLC was awarded a purchase order contract valued at $2,461 by the Defense Logistics Agency Troop Support Medical. The contract is for the delivery of a training device for nerve agent antidotes by December 27, 2023. No set-aside designation was used for this award. Meridian will provide one TRAINING DEVICE,DIA at its place of performance in Columbia, Maryland. Meridian is a manufacturer and provider of medical training services owned by Pfizer Inc., a large...
Mylan Specialty L.P. was awarded a definitive contract by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to purchase epinephrine auto-injectors for the Strategic National Stockpile. Valued at $8.25 million, this firm fixed price contract will provide funding to procure these medical devices to support the federal government's ongoing COVID-19 response efforts over an 11-day period of performance in Chamblee, Georgia. No subcontractors...
This federal contract award, valued at $2,613.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Epinephrine 0.3 mg auto-injectors, a critical medical product used to treat severe allergic reactions. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00. This IDC enables the company to supply a...
This federal contract award is for the delivery of 4,564,375 units of the epinephrine 0.3 mg auto-injector medical device, valued at $1,378.08. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This single-award IDC...